辰欣药业股份有限公司 关于变更保荐代表人的公告

Core Viewpoint - The announcement details the change of the sponsor representative for the ongoing supervision of the initial public offering (IPO) of Chenxin Pharmaceutical Co., Ltd. by Zhongtai Securities Co., Ltd. [1] Group 1: Change of Sponsor Representative - Zhongtai Securities has appointed Suo Jianpeng as the new sponsor representative to replace Zeng Liping, who has been reassigned to other responsibilities [1] - The ongoing supervision will continue until the obligations set by the China Securities Regulatory Commission and the Shanghai Stock Exchange are fulfilled [1] Group 2: Acknowledgment of Contributions - The board of directors expresses gratitude for Zeng Liping's contributions during her tenure as the sponsor representative [2] Group 3: Background of New Representative - Suo Jianpeng is the Vice President of the Investment Banking Business Committee at Zhongtai Securities and has previously participated in various IPO projects [3]